Artelo Biosciences (ARTL) investors disclose 4.8% stake via Intracoastal warrant

Rhea-AI Filing Summary

Artelo Biosciences, Inc. is reported as having a significant shareholder group consisting of Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC. As of the close of business on June 30, 2026, they may be deemed to have beneficial ownership of 173,914 shares of common stock, all issuable upon exercise of a warrant held by Intracoastal. This represents 4.8% of the common stock, based on 3,485,540 shares outstanding as of May 26, 2026 plus the warrant shares. The group reports no sole voting or dispositive power and shared voting and dispositive power over all 173,914 warrant shares, and indicates ownership of 5 percent or less of the class.

Key Figures

Beneficially owned shares: 173,914 shares Ownership percentage: 4.8% Shares outstanding: 3,485,540 shares +2 more

5 metrics

Beneficially owned shares 173,914 shares Common stock issuable upon exercise of the Intracoastal Warrant as of June 30, 2026

Ownership percentage 4.8% Percentage of Artelo Biosciences common stock beneficially owned by the reporting persons

Shares outstanding 3,485,540 shares Common stock outstanding as of May 26, 2026, as reported to the holders

Sole voting power 0 shares Number of shares over which the group reports sole power to vote

Shared voting power 173,914 shares Number of shares over which the group reports shared power to vote

Key Terms

beneficial ownership, Schedule 13G/A, warrant, shared dispositive power, +1 more

5 terms

beneficial ownership financial

"each of the Reporting Persons may have been deemed to have beneficial ownership of 173,914 shares"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Schedule 13G/A regulatory

"CONTENT METADATA: "form_type": "SCHEDULE 13G/A""

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

warrant financial

"173,914 shares of Common Stock issuable upon exercise of a warrant held by Intracoastal"

A warrant is a time-limited financial contract that gives its holder the right to buy a company's shares at a set price before a specified date, like a coupon that lets you purchase stock at a fixed discount for a limited time. It matters to investors because warrants offer leveraged exposure to a stock’s upside and can dilute existing shareholders if exercised, so they affect potential gains and the company’s outstanding share count.

shared dispositive power financial

"Shared Dispositive Power 173,914.00"

percent of class financial

"Percent of class: 4.8%"

Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

FAQ

What ownership stake in Artelo Biosciences (ARTL) do the reporting persons disclose?

The reporting persons disclose beneficial ownership of 173,914 shares of Artelo Biosciences common stock, all issuable upon exercise of a warrant, representing 4.8% of the outstanding common stock as of the referenced dates.

How is the 4.8% ownership in Artelo Biosciences (ARTL) calculated?

The 4.8% stake is based on 3,485,540 shares of common stock outstanding as of May 26, 2026, plus 173,914 shares issuable upon exercise of the Intracoastal warrant, which together form the denominator for the percentage calculation.

Who are the reporting persons in this Artelo Biosciences (ARTL) Schedule 13G/A?

The filing is made on behalf of Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC. Intracoastal holds the warrant, and each reporting person may be deemed to share beneficial ownership of the underlying common stock.

What voting and dispositive powers are reported for the Artelo Biosciences (ARTL) shares?

The group reports 0 shares with sole voting or dispositive power and 173,914 shares with shared voting and shared dispositive power, all corresponding to the common stock issuable upon exercise of the Intracoastal warrant.

Does this Artelo Biosciences (ARTL) Schedule 13G/A show ownership above or below 5%?

The filing states beneficial ownership of approximately 4.8% of Artelo Biosciences common stock and includes an indication of ownership of 5 percent or less of the class, placing the group below the 5% threshold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 10:16 AM Accepted by SEC EDGAR 08/13/2026 - 10:16 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Artelo Biosciences, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

04301G706

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 04301G706

1

Names of Reporting Persons

Mitchell P. Kopin

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 173,914.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 173,914.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

173,914.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.8 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

CUSIP Number(s): 04301G706

1

Names of Reporting Persons

Daniel B. Asher

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 173,914.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 173,914.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

173,914.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.8 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

CUSIP Number(s): 04301G706

1

Names of Reporting Persons

Intracoastal Capital LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 173,914.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 173,914.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

173,914.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.8 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Artelo Biosciences, Inc.
(b)	Address of issuer's principal executive offices: 505 Lomas Santa Fe, Suite 160, Solana Beach, CA 92075
Item 2.
(a)	Name of person filing: This Schedule 13G is being filed on behalf of (i) Mitchell P. Kopin, an individual ("Mr. Kopin"), (ii) Daniel B. Asher, an individual ("Mr. Asher") and (iii) Intracoastal Capital LLC, a Delaware limited liability company ("Intracoastal" and together with Mr. Kopin and Mr. Asher, collectively the "Reporting Persons").
(b)	Address or principal business office or, if none, residence: The principal business office of Mr. Kopin and Intracoastal is 245 Palm Trail, Delray Beach, Florida 33483. The principal business office of Mr. Asher is 1011 Lake Street, Suite 311, Oak Park, Illinois 60301.
(c)	Citizenship: Mr. Kopin is a citizen of the United States of America. Mr. Asher is a citizen of the United States of America. Intracoastal is a Delaware limited liability company.
(d)	Title of class of securities: Common Stock, par value $0.001 per share
(e)	CUSIP No.: 04301G706
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: As of the close of business on June 30, 2026, each of the Reporting Persons may have been deemed to have beneficial ownership of 173,914 shares of Common Stock issuable upon exercise of a warrant held by Intracoastal (the "Intracoastal Warrant"), and all such shares of Common Stock represent beneficial ownership of approximately 4.8% of the Common Stock, based on (1) 3,485,540 shares of Common Stock outstanding as of May 26, 2026, as reported to the Reporting Persons by the Issuer and (2) 173,914 shares of Common Stock issuable upon exercise of the Intracoastal Warrant.
(b)	Percent of class: 4.8%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 173,914
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 173,914
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Mitchell P. Kopin

Signature:	/s/ Mitchell P. Kopin
Name/Title:	Mitchell P. Kopin
Date:	08/13/2026

Daniel B. Asher

Signature:	/s/ Daniel B. Asher
Name/Title:	Daniel B. Asher
Date:	08/13/2026

Intracoastal Capital LLC

Signature:	/s/ Mitchell P. Kopin
Name/Title:	Mitchell P. Kopin, Manager
Date:	08/13/2026